| Syed Farhan Zaidi, MD | |
|
1344 S Apollo Blvd Ste 300, Melbourne, FL 32901-3185 | |
| (321) 725-2225 | |
| (321) 308-0635 |
| Full Name | Syed Farhan Zaidi |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 24 Years |
| Location | 1344 S Apollo Blvd Ste 300, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215940564 | NPI | - | NPPES |
| 002573200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | ME107480 (Florida) | Primary |
| Entity Name | Brevard Orthopaedic Spine & Pain Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548237100 PECOS PAC ID: 8628050515 Enrollment ID: O20040603001297 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | First Choice Medical Group Of Brevard Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578846564 PECOS PAC ID: 8628240884 Enrollment ID: O20111012000034 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | Mdpa Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992181077 PECOS PAC ID: 8921301300 Enrollment ID: O20160119000856 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356654495 PECOS PAC ID: 2860688728 Enrollment ID: O20170602001215 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | Restore Spine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952925547 PECOS PAC ID: 6406271246 Enrollment ID: O20200811000026 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | Glomar Medical Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053913095 PECOS PAC ID: 0244644862 Enrollment ID: O20210122000268 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Entity Name | Syed Farhan Zaidi Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093420127 PECOS PAC ID: 4880068220 Enrollment ID: O20230324002674 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Syed Farhan Zaidi, MD 2222 S Harbor City Blvd Ste 610, Melbourne, FL 32901-5591 Ph: (321) 723-7716 | Syed Farhan Zaidi, MD 1344 S Apollo Blvd Ste 300, Melbourne, FL 32901-3185 Ph: (321) 725-2225 |
News Archive
To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus have been poorly understood, which has hampered efforts to develop treatments to prevent complications from a disease that is the third leading cause of death in the United States.
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.
Today's headlines include reports from the marketplace, including UnitedHealthcare's move toward the health law's insurance marketplaces and the latest on the Securities and Exchange Commission investigation into insider trading related to a health policy change.
Alere Inc., a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics in the hands of patients to their healthcare providers, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
› Verified 6 days ago
Dr. Dionne Docile Casthely, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 101 E Florida Ave, Melbourne, FL 32901 Phone: 321-872-8770 Fax: 321-574-3815 | |
Jay Edward Olsson, DO PROF ASSOCIATIONN Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 N Wickham Rd, Suite S, Melbourne, FL 32935 Phone: 321-242-9031 Fax: 321-242-9035 | |
Mary Lou Mcintyre, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6845 Murrell Rd, Melbourne, FL 32940 Phone: 786-770-9480 | |
Pamela Dorman, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8725 N Wickham Rd Ste 301, Melbourne, FL 32940 Phone: 321-434-9200 | |
Dr. Mahathy Katukuri, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7332 Office Park Pl Ste 103, Melbourne, FL 32940 Phone: 321-327-9788 | |
John C Madlener, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 903 Jordan Blass Dr, Suite 102, Melbourne, FL 32940 Phone: 321-751-5351 Fax: 321-751-5370 |